Phase 1 Nasopharyngeal Carcinoma Clinical Trials

8 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–8 of 8 trials

Recruiting

Phase 1

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Metastatic Head and Neck Squamous Cell CarcinomaStage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8Recurrent Head and Neck Squamous Cell Carcinoma+20 more

Emory University40 enrolled2 locationsNCT06868433

Recruiting

Phase 1Phase 2

A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.

Recurrent or Metastatic Nasopharyngeal Carcinoma

MediLink Therapeutics (Suzhou) Co., Ltd.202 enrolled20 locationsNCT07258979

Recruiting

Phase 1Phase 2

SSTR2 Imaging With [68Ga]Ga-DOTA-TOC PET/CT in NPC

Nasopharyngeal Carcinoma (NPC)

University Medical Center Groningen10 enrolled1 locationNCT06982300

Recruiting

Phase 1Phase 2

EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma

Nasopharyngeal Cancinoma (NPC)Metastatic Nasopharyngeal CarcinomaRecurrent Nasopharynx Carcinoma

Sun Yat-Sen University Cancer Center148 enrolled1 locationNCT06802835

Recruiting

Phase 1

Metastatic Nasopharyngeal Carcinoma

Chen Xiaozhong47 enrolled1 locationNCT06886347

Recruiting

Phase 1

Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma (NPC)

Sun Yat-sen University24 enrolled1 locationNCT06611150

Completed

Phase 1

Killer T cell Therapy for Nasopharyngeal Carcinoma

Epstein-Barr virus associated Nasopharyngeal Carcinoma

The University of Hong Kong50 enrolled1 locationACTRN12609000675224

Completed

Phase 1

Phase I Trial of Adoptive Immunotherapy for Stage III and IV Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Queensland Institute of Medical Research10 enrolled1 locationACTRN12607000191493